Genentech
The Scientist 3 role involves independently executing and optimizing the synthesis of targeted and non-targeted lipid nanoparticles (LNPs) for nucleic acid delivery. The position requires leading design of experiments (DoE) screening campaigns, collaborating cross-functionally, and supporting formulation development and downstream processing. The successful candidate will analyze experimental data, troubleshoot challenges, and maintain detailed records to advance non-viral delivery platforms.
Headquarters
South San Francisco, California, United States
Company Size
10001+ employees
Founded
1976
Genentech is a research-driven biotechnology company that develops medicines through breakthrough science to treat people with serious and life‑threatening diseases. It discovers, advances and manufactures biologic therapies — including monoclonal antibodies and targeted medicines — across oncology, immunology, neuroscience and other therapeutic areas, moving candidates through discovery and clinical trials. Founded in 1976 and now part of the Roche group, Genentech is known for its patient-centered focus and for translating deep science into transformative, widely used medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genentech.
Scientist I - LNP
Dawar Consulting
Associate Scientist, Non Viral Delivery Technologies (Regeneron Genetics Medicines) 2
Regeneron Pharmaceuticals
Scientist I – Lipid Nanoparticles
Dawar Consulting
Scientist
Serif
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Scientist, Drug Product Analytical
NewLimit